These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38000646)

  • 1. Emerging pollutants in etiology and pathophysiology of polycystic ovary syndrome.
    Gautam R; Prambil AM; Patel AK; Arora T
    Reprod Toxicol; 2024 Jan; 123():108515. PubMed ID: 38000646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of endocrine-disrupting chemicals on polycystic ovarian syndrome: A comprehensive review.
    Jala A; Varghese B; Kaur G; Rajendiran K; Dutta R; Adela R; Borkar RM
    Environ Sci Pollut Res Int; 2022 Aug; 29(39):58484-58513. PubMed ID: 35778660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion.
    Soave I; Occhiali T; Assorgi C; Marci R; Caserta D
    Curr Med Res Opin; 2020 Apr; 36(4):693-703. PubMed ID: 32046531
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphenol-A and polycystic ovary syndrome: a review of the literature.
    Kechagias KS; Semertzidou A; Athanasiou A; Paraskevaidi M; Kyrgiou M
    Rev Environ Health; 2020 Nov; 35(4):323-331. PubMed ID: 32663175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome and environmental toxins.
    Rutkowska AZ; Diamanti-Kandarakis E
    Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.
    Jozkowiak M; Piotrowska-Kempisty H; Kobylarek D; Gorska N; Mozdziak P; Kempisty B; Rachon D; Spaczynski RZ
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).
    Palioura E; Diamanti-Kandarakis E
    Rev Endocr Metab Disord; 2015 Dec; 16(4):365-71. PubMed ID: 26825073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industrial endocrine disruptors and polycystic ovary syndrome.
    Palioura E; Diamanti-Kandarakis E
    J Endocrinol Invest; 2013 Dec; 36(11):1105-11. PubMed ID: 24445124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.
    Bruni V; Capozzi A; Lello S
    Reprod Sci; 2022 Mar; 29(3):668-679. PubMed ID: 33709373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects.
    Palioura E; Kandaraki E; Diamanti-Kandarakis E
    Horm Mol Biol Clin Investig; 2014 Mar; 17(3):137-44. PubMed ID: 25372737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.
    Eiras MC; Pinheiro DP; Romcy KAM; Ferriani RA; Reis RMD; Furtado CLM
    Reprod Sci; 2022 Mar; 29(3):680-694. PubMed ID: 33826098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
    Siddiqui S; Mateen S; Ahmad R; Moin S
    J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: a preliminary investigation].
    Li TT; Xu LZ; Chen YH; Deng HM; Liang CY; Liu Y; Liu XF; Zhang J; Kang DY; Qiu DS; Han DW; Hu R
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1753-6. PubMed ID: 22027783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome.
    Shukla P; Mukherjee S
    Mitochondrion; 2020 May; 52():24-39. PubMed ID: 32081727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine disrupting chemical Bisphenol A and its potential effects on female health.
    Kawa IA; Akbar Masood ; Fatima Q; Mir SA; Jeelani H; Manzoor S; Rashid F
    Diabetes Metab Syndr; 2021; 15(3):803-811. PubMed ID: 33839640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).
    Rutkowska A; Rachoń D
    Gynecol Endocrinol; 2014 Apr; 30(4):260-5. PubMed ID: 24397396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome.
    Hewlett M; Chow E; Aschengrau A; Mahalingaiah S
    Reprod Sci; 2017 Jan; 24(1):19-27. PubMed ID: 27342273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study.
    Vagi SJ; Azziz-Baumgartner E; Sjödin A; Calafat AM; Dumesic D; Gonzalez L; Kato K; Silva MJ; Ye X; Azziz R
    BMC Endocr Disord; 2014 Oct; 14():86. PubMed ID: 25348326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine-disrupting chemicals and hormonal profiles in PCOS women: A comparative study between urban and rural environment.
    Patel J; Chaudhary H; Panchal S; Joshi T; Joshi R
    Reprod Toxicol; 2024 Apr; 125():108562. PubMed ID: 38417580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development.
    Abruzzese GA; Silva AF; Velazquez ME; Ferrer MJ; Motta AB
    WIREs Mech Dis; 2022 Sep; 14(5):e1558. PubMed ID: 35475329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.